These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 20492324)

  • 61. Environmental and genetic determinants of fatty liver in humans.
    Kantartzis K; Schick F; Häring HU; Stefan N
    Dig Dis; 2010; 28(1):169-78. PubMed ID: 20460907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fatty liver disease in obese children--relation to other metabolic risk factors.
    Volovelsky O; Weiss R
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Animal models of non-alcoholic steatohepatitis: of mice and man.
    Schattenberg JM; Galle PR
    Dig Dis; 2010; 28(1):247-54. PubMed ID: 20460919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nutritional status, genetic susceptibility, and insulin resistance--important precedents to atherosclerosis.
    McGillicuddy FC; Roche HM
    Mol Nutr Food Res; 2012 Jul; 56(7):1173-84. PubMed ID: 22760984
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
    Kirovski G; Dorn C; Huber H; Moleda L; Niessen C; Wobser H; Schacherer D; Buechler C; Wiest R; Hellerbrand C
    Exp Mol Pathol; 2011 Dec; 91(3):780-3. PubMed ID: 21855538
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [NASH in children].
    Ida S; Yoshimura N
    Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R; Musso G; Cassader M
    Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonalcoholic fatty liver disease.
    Krawczyk M; Bonfrate L; Portincasa P
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):695-708. PubMed ID: 20955971
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G
    Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 72. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
    Yilmaz Y
    Semin Liver Dis; 2012 Feb; 32(1):14-21. PubMed ID: 22418884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nonalcoholic fatty liver disease and lipids.
    Wierzbicki AS; Oben J
    Curr Opin Lipidol; 2012 Aug; 23(4):345-52. PubMed ID: 22617751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
    Scorletti E; Byrne CD
    Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
    Asrih M; Jornayvaz FR
    J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Obesity: a complex growing challenge.
    Pataky Z; Bobbioni-Harsch E; Golay A
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):427-33. PubMed ID: 19856250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin resistance at the crossroads of metabolic syndrome: systemic analysis using microarrays.
    Kim E
    Biotechnol J; 2010 Sep; 5(9):919-29. PubMed ID: 20669253
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Role of oxidative stress in non-alcoholic steatohepatitis].
    Mitsuyoshi H; Itoh Y; Okanoue T
    Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.